Natural Health Trends Corp. — FY2020 Form 10-K
Reporting period: Fiscal year ended December 31, 2020. The filing is an annual report, not a standalone Q4 filing; fourth-quarter figures are also summarized below. The company sells NHT Global wellness, personal-care and lifestyle products through direct-selling and e-commerce channels. Its business is highly concentrated in Hong Kong revenue, substantially all of which comes from products delivered to members in China.
Financial performance
| Metric | FY2020 | FY2019 |
|---|---|---|
| Net sales | $62.1 million | $77.6 million |
| Gross profit / gross margin | $45.1 million / 72.6% | $57.5 million / 74.1% |
| Operating income (loss) / margin | $0.7 million / 1.1% | $(7.0) million / (9.1)% |
| Net income (loss) / diluted EPS | $0.8 million / $0.07 | $(5.6) million / $(0.52) |
| Operating cash flow | $1.9 million provided | $18.6 million used |
- Sales declined 20%. Hong Kong sales fell 22% to $49.2 million and represented 79.2% of total sales. Management attributed the decline to COVID-19 restrictions, the continuing effects of China’s 100-day campaign and related review, and disruption in other markets.
- Gross margin contracted 1.5 percentage points, primarily from higher logistics costs and product promotions. Commissions declined to 42.2% of sales from 45.8%; SG&A fell 33% to $18.2 million, including lower employee, professional-fee and event costs. FY2019 included a $1.8 million goodwill impairment; FY2020 did not.
- Cash and cash equivalents were $92.4 million at year-end, including $68.4 million of available-for-sale investments classified as cash equivalents. A further $0.5 million was restricted cash. The company reported $12.5 million held in China subject to foreign-currency controls.
- Working capital was $78.2 million and the current ratio was 4.64. No borrowings are reported in the presented balance sheet; operating lease liabilities totaled $3.9 million.
- Investing cash outflow was $0.2 million. Financing cash outflow was $9.1 million, entirely reported as dividends paid. Year-end cash, cash equivalents and restricted cash totaled $92.9 million, down $6.5 million from the start of the year.
- Quarter four sales were $16.6 million, versus $17.8 million in Q4 2019. Q4 operating income was $1.3 million versus an operating loss of $3.2 million; net income was $0.7 million versus a net loss of $2.8 million.
Material changes and business developments
- Active members fell to 52,230 from 57,410, a 9% decrease. Management linked member losses to lower sales and noted that the company has not replaced departing members as effectively as in the past.
- Administrative fees increased by $2.3 million following a June 2020 change to fees for certain Hong Kong eWallet accounts, partially cushioning the sales decline.
- The company received a $2.9 million refund in March 2020 of a China consumer-protection deposit after withdrawing its pending direct-selling license application. It may reapply, but timing, approval and profitability are uncertain.
- The company paid $0.20 per share in each 2020 quarter, totaling $9.1 million. The board declared another $0.20 quarterly dividend in February 2021; future dividends remain discretionary.
Outlook, risks and unusual items
- Management expects near-term results may remain adversely affected by COVID-19, Chinese restrictions and logistics disruption. February 2021 restrictions ahead of Chinese New Year were expected to reduce first-quarter working days and could weigh on sales. No numerical earnings or revenue guidance was provided.
- Geographic concentration is a major risk: Hong Kong generated 79% of revenue, with substantially all Hong Kong revenue tied to deliveries to members in China. China regulatory scrutiny, the 100-day campaign and its continuing look-back review could result in restrictions, penalties or business-model changes. The company does not hold a China direct-selling license.
- Other material risks include Hong Kong political and social disruption, member attrition, foreign-exchange exposure, competition, reliance on third-party manufacturers and logistics providers, and single-supplier sourcing for three products that each contribute at least 10% of revenue.
- The SEC is conducting a non-public investigation concerning possible federal securities-law violations related to trading in the company’s securities and/or public disclosures. The company says it is cooperating and cannot predict the outcome. A securities class action was dismissed with prejudice; the plaintiff voluntarily dismissed the appeal in April 2020.
- The 2020 tax provision was $647,000, including an estimated GILTI inclusion, partly offset by a $512,000 benefit from carrying back 2019 net operating losses under the CARES Act. The auditor issued an unqualified opinion on the financial statements and identified commissions expense and accrued commissions as a critical audit matter. Management assessed internal control over financial reporting as effective; the auditor did not express an opinion on internal controls.
Important facts for investors to verify
- Whether sales, member counts and operating cash flow stabilize, especially in Hong Kong and China, and whether the Q4 improvement continued after year-end.
- How much reported revenue depends on Chinese consumers despite being recorded as Hong Kong revenue, and the consequences of regulatory changes or enforcement.
- Cash accessibility, including funds subject to Chinese currency controls, and the sustainability of dividends given modest 2020 operating cash flow and $9.1 million of dividends paid.
- Potential outcomes and costs of the SEC investigation, and any developments in China-related compliance matters.
- Supply continuity and concentration risks for Premium Noni Juice, Enhanced Essential Probiotics and Triotein, each sourced from a single supplier.